Neutropenia associated with X-linked agammaglobulinemia in an Iranian Referral Center

Iranian Journal of Allergy, Asthma and Immunology

Volumn 8, Issue 1, 2009, Pages 43-47

  Aghamohammadi, Asghar ^a,b,c   Cheraghi, Taher ^a   Rezaei, Nima ^c   Kanegane, Hirokazu ^d   Abdollahzede, Sina ^b   Talaei Khoei, Mojtaba ^b   Heidari, Golnaz ^b   Zandieh, Fariborz ^a   Moin, Mostafa ^a,c   Miyawaki, Toshio ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Intravenous immunoglobulin; Neutropenia; X linked agammaglobulinemia

Indexed keywords

IMMUNOGLOBULIN; AGAMMAGLOBULINAEMIA TYROSINE KINASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN TYROSINE KINASE;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; IRAN; NEUTROPENIA; RECURRENT INFECTION; X LINKED AGAMMAGLOBULINEMIA; AGAMMAGLOBULINEMIA; BLOOD; COMMUNICABLE DISEASE; GENETICS; INFANT; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; METABOLISM; NEUTROPHIL; ONSET AGE; PATHOLOGY; PRESCHOOL CHILD; X CHROMOSOME LINKED DISORDER;

ADOLESCENT; ADULT; AGAMMAGLOBULINEMIA; AGE OF ONSET; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; IRAN; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; NEUTROPENIA; NEUTROPHILS; PROTEIN-TYROSINE KINASES; YOUNG ADULT;

EID: 69249229781     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bruton OC. Agammaglobulinemia. Pediatrics 1952; 9(6):722-8.
2. Ochs HD, Smith CI. X-linked agammaglobulinemia. A clinical and molecular analysis. Medicine (Baltimore) 1996; 75(6):287-99.
3. Sideras P, Smith CI. Molecular and cellular aspects of X-linked agammaglobulinemia. Adv Immunol 1995; 59:135-223.
4. Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993; 361(6409):226-33.
5. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993; 72(2):279-90.
6. Moin M, Aghamohammadi A, Farhoudi A, Pourpak Z, Rezaei N, Movahedi M, et al. X-linked agammaglobulinemia: a survey of 33 Iranian patients. Immunol Invest 2004; 33(1):81-93.
7. Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 2006; 85(4):193-202.
8. Aghamohammadi A, Moin M, Farhoudi A, Rezaei N, Pourpak Z, Movahedi M, et al. Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia. Fems Immunology and Medical Microbiology 2004; 40(2):113-8.
9. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002; 109(6):1001-4.
10. Mangla A, Khare A, Vineeth V, Panday NN, Mukhopadhyay A, Ravindran B, et al. Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses. Blood 2004; 104(4):1191-7.
11. Futatani T, Watanabe C, Baba Y, Tsukada S, Ochs HD. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. British Journal of Haematology 2001; 114(1):141-9.
12. Futatani T, Miyawaki T, Tsukada S, Hashimoto S, Kunikata T, Arai S, et al. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 1998; 91(2):595-602.
13. Kanegane H, Taneichi H, Nomura K, Futatani T, Miyawaki T. Severe neutropenia in Japanese patients with X-linked agammaglobulinemia. Journal of Clinical Immunology 2005; 25(5):491-5.
14. Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) 1985; 64(3):145-56.
15. Farrar JE, Rohrer J, Conley ME. Neutropenia in X-linked agammaglobulinemia. Clin Immunol Immunopathol 1996; 81(3):271-6.
16. Plo Rodriguez F, Garcia Rodriguez MC, Ferreira Cerdan A, Fontan Casariego G. [Neutropenia as early manifestation of X-linked agammaglobulinemia. Report on 4 patients]. An Esp Pediatr 1999; 51(3):235-40.
17. Aghamohammadi A, Moein M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, et al. Primary immunodeficiency in Iran: first report of the National Registry of PID in Children and Adults. J Clin Immunol 2002; 22(6):375-80.
18. Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in iran: update from the Iranian primary immunodeficiency registry. J Clin Immunol 2006; 26(6):519-32.
19. Aghamohammadi A, Amirzargar AA, Parvaneh N. deficienct expression of Bruton's Tyrosine Kinase in monocytes from X-linked Agammaglubolinemia as evaluated by flowcytometric analysis and its clinical application in carrier detection. Iran J Immunol 2005; 2(4):202-8.
20. Aghamohammadi A, Fiorini M, Moin M, Parvaneh N, Teimourian S, Yeganeh M, et al. Clinical, Immunological and Molecular Characteristics of 37 Iranian Patients with X-Linked Agammaglobulinemia. Int Arch Allergy Immunol 2006; 141(4):408-14.
21. Kozlowski C, Evans DI. Neutropenia associated with X-linked agammaglobulinaemia. J Clin Pathol 1991; 44(5):388-90.
22. Cham B, Bonilla MA, Winkelstein J. Neutropenia associated with primary immunodeficiency syndromes. Semin Hematol 2002; 39(2):107-12.
23. Rezaei N, Farhoudi A, pourpak Z, Aghamohammadi A, Moin M, Gharagozlou M, et al. Neutropenia in patients with primary antibody deficiency disorders. Iran J Allergy Asthma Immunol 2004; 3(2):77-81.
24. Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Moin M, Movahedi M, et al. Neutropenia in Iranian patients with primary immunodeficiency disorders. Haematologica 2005; 90(4):554-6.
25. Conley ME, Park CL, Douglas SD. Childhood common variable immunodeficiency with autoimmune disease. J Pediatr 1986; 108(6):915-22.
26. Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). Journal of Autoimmunity 2005; 25(1):57-62.
27. Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003; 82(6):373-84.
28. Mori M, Nonoyama S, Neubauer M, Mitsuda T, Kosuge K, Yokota S. Mutation analysis and therapeutic response to granulocyte colony-stimulating factor in a case of hyperimmunoglobulin M syndrome with chronic neutropenia. J Pediatr Hematol Oncol 2000; 22(3):288-9.
29. Atarod L, Aghamohammadi A, Moin M, Kanegane H, Rezaei N, Rezaei Kalantari K, et al. Successful Management of Neutropenia in a Patient with CD40 Ligand Deficiency by Immunoglobulin Replacement Therapy. Iran J Allergy Asthma Immunol 2007; 6(1):37-40.
30. Futatani T, Miyawaki T, Tsukada S, Hashimoto S, Kunikata T, Arai S, et al. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. . Blood 1998; 91:595-602.
31. Amoras AL, Kanegane H, Miyawaki T, Vilela MM. Defective Fc-, CR1- and CR3-mediated monocyte phagocytosis and chemotaxis in common variable immunodeficiency and X-linked agammaglobulinemia patients. Journal of Investigational Allergology & Clinical Immunology 2003; 13(3):181-8.
32. Horwood NJ, Mahon T, McDaid JP, Campbell J, Mano H, Brennan FM, et al. Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production. J Exp Med 2003; 197(12):1603-11.
33. Jefferies CA, Doyle S, Brunner C, Dunne A, Brin E, Wietek C, et al. Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by toll-like receptor 4. Journal of Biological Chemistry 2003; 278(28):26258-64.